Beta-catenin switch in apoptosis-resistant and hormone-refractory prostate cancer cells

被引：0
|
作者：
Quires, L
Rubin, M
Vacherot, F
Chen, MW
Diez, SG
Salomon, L
Burchardt, M
Abbou, C
Buttyan, R
Chopin, D
De La Taille, A
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
834
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [41] Neuroendocrine differentiation and hormone-refractory prostate cancer
    Abrahamsson, PA
    [J]. PROSTATE, 1996, : 3 - 8
  • [42] METRONOMIC CYCLOPHOSPHAMIDE IN HORMONE-REFRACTORY PROSTATE CANCER
    Baldazzi, Valentina
    Tassi, Renato
    Lapini, Alberto
    Lunghi, Alice
    Carini, Marco
    Mazzanti, Roberto
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1459 - 1460
  • [43] Docetaxel for hormone-refractory prostate cancer Reply
    Damber, Jan-Erik
    Aus, Gunnar
    [J]. LANCET, 2008, 372 (9648): : 1461 - 1462
  • [44] Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells
    Lee, Eugine
    Ha, Susan
    Logan, Susan K.
    [J]. PLOS ONE, 2015, 10 (10):
  • [45] Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
    Tsakalozou, Eleftheria
    Eckman, Allison M.
    Bae, Younsoo
    [J]. BIOCHEMISTRY RESEARCH INTERNATIONAL, 2012, 2012
  • [46] Redistribution of androgen receptors in acquired hormone-refractory prostate cancer cells
    Yu, D. S.
    Hsieh, D. S.
    Chang, S. Y.
    [J]. ARCHIVES OF ANDROLOGY, 2006, 52 (05): : 389 - 395
  • [47] Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer
    Uzzo, Robert G.
    Haas, Naomi B.
    Crispen, Paul L.
    Kolenko, Vladimir M.
    [J]. CANCER, 2008, 112 (08) : 1660 - 1671
  • [48] New therapeutic agents for hormone-refractory prostate cancer
    Roth, BJ
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (06) : 49 - 55
  • [49] Differential gene expression in hormone-refractory prostate cancer
    Fromont, G
    Chene, L
    Vidaud, M
    Mahouche, I
    Vallancien, G
    Validire, P
    Latil, A
    Cussenot, O
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 150A - 150A
  • [50] Hormone-refractory prostate cancer: An evolving standard of care
    Small, EJ
    Reese, DM
    Vogelzang, NJ
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (05) : 61 - 67
12345